High-dose statin monotherapy versus low-dose statin/ezetimibe combination on fasting and postprandial lipids and endothelial function in obese patients with the metabolic syndrome: The PANACEA study

► Simvastatin (80 mg) and simvastatin/ezetimibe (10/10 mg) were investigated in metabolic syndrome. ► There was no difference in fasting and postprandial lipids and glucose. ► There was no difference in fasting and postprandial endothelial function. ► There was no difference in fasting and postprandial heart rate variability.